These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27790892)

  • 1. [New biomarkers for assesing alcohol consumption].
    Aakerøy R; Skråstad RB; Helland A; Hilberg T; Aamo T; Dyrkorn R; Spigset O
    Tidsskr Nor Laegeforen; 2016 Oct; 136(19):1643-1647. PubMed ID: 27790892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting.
    Helander A; Péter O; Zheng Y
    Alcohol Alcohol; 2012; 47(5):552-7. PubMed ID: 22691387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B-PEth and other markers of excessive alcohol us. A comparative study in general practice].
    Bjerre B
    Lakartidningen; 2009 Apr 7-21; 106(15-16):1099-100, 1102-3. PubMed ID: 19492677
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level.
    Walther L; de Bejczy A; Löf E; Hansson T; Andersson A; Guterstam J; Hammarberg A; Asanovska G; Franck J; Söderpalm B; Isaksson A
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2200-8. PubMed ID: 26503066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on the Paper of Walther L. et al.: Phosphatidylethanol is Superior to CDT and GGT as an Alcohol Marker and Is a Reliable Estimate of Alcohol Consumption Level.
    Weinmann W; Schröck A; Wurst FM
    Alcohol Clin Exp Res; 2016 Feb; 40(2):260-2. PubMed ID: 26833179
    [No Abstract]   [Full Text] [Related]  

  • 6. The PEth Blood Test in the Security Environment: What it is; Why it is Important; and Interpretative Guidelines.
    Ulwelling W; Smith K
    J Forensic Sci; 2018 Nov; 63(6):1634-1640. PubMed ID: 30005144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers can detect early-stage alcohol problems].
    Helander A
    Lakartidningen; 2011 Oct 9-15; 108(45):2291-5. PubMed ID: 22242244
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein biomarkers of alcohol abuse.
    Torrente MP; Freeman WM; Vrana KE
    Expert Rev Proteomics; 2012 Aug; 9(4):425-36. PubMed ID: 22967079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 'state' markers for the detection of alcoholism.
    Lesch OM; Walter H
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):59-62. PubMed ID: 9845039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse.
    Isaksson A; Walther L; Hansson T; Andersson A; Alling C
    Drug Test Anal; 2011 Apr; 3(4):195-200. PubMed ID: 21438164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of direct alcohol markers: a review.
    Cabarcos P; Álvarez I; Tabernero MJ; Bermejo AM
    Anal Bioanal Chem; 2015 Jul; 407(17):4907-25. PubMed ID: 25935676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.
    Aradottir S; Asanovska G; Gjerss S; Hansson P; Alling C
    Alcohol Alcohol; 2006; 41(4):431-7. PubMed ID: 16624837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New applications of contemporary biomarkers of alcohol consumption.
    Bean P; De Bruin T; Harasymiw J; Hallinan P
    Am Clin Lab; 2002 Mar; 21(2):19-21. PubMed ID: 11993250
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study.
    Kechagias S; Dernroth DN; Blomgren A; Hansson T; Isaksson A; Walther L; Kronstrand R; Kågedal B; Nystrom FH
    Alcohol Alcohol; 2015 Jul; 50(4):399-406. PubMed ID: 25882743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How has screening of harmful drinking changed over the years?
    Vincenti M; Salomone A; Pirro V
    Bioanalysis; 2013 Dec; 5(24):2981-3. PubMed ID: 24320123
    [No Abstract]   [Full Text] [Related]  

  • 16. Limitations of CDT and GGT in detecting relapses in patients attending an alcohol problems clinic.
    Limin S; Jarvie DR; Chick J; Simpson D
    Scott Med J; 1999 Oct; 44(5):140-2. PubMed ID: 10629909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism.
    Schmidt LG; Schmidt K; Dufeu P; Ohse A; Rommelspacher H; Müller C
    Am J Psychiatry; 1997 Jan; 154(1):75-80. PubMed ID: 8988962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survey of alcohol drinking and results of studies of alcoholism biological markers within the scope of a neurologic occupational medicine study of industrial workers].
    Reinhardt F; Katalinic A; Neundörfer B
    Versicherungsmedizin; 1996 Jun; 48(3):101-3. PubMed ID: 8737548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum.
    Stibler H; Borg S; Joustra M
    Alcohol Alcohol Suppl; 1991; 1():451-4. PubMed ID: 1845576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.